Bharat Biotech begins export of Covaxin

Our Bureau Updated - November 29, 2021 at 02:30 PM.

Exports to additional countries will commence from December

Vials of the Covaxin Covid-19 vaccine at a vaccination center, that is administering Covaxin and Covishield, set up at a school in New Delhi, India, on Wednesday, Nov. 24, 2021. Covaxin, one of the main vaccines used in India's coronavirus immunization drive, provides only 50% protection against symptomatic Covid-19, according to a real-world study that suggests the shot is less effective than initially thought. Photographer: T. Narayan/Bloomberg

Bharat Biotech International Limited has commenced export of its Covid vaccine, Covaxin. “Long-pending export orders have been executed during November, to be further expanded during the following months,” said the Hyderabad based company in a release on Tuesday.

Bharat Biotech: More than just Covaxin

With the number of countries that have granted emergenc- use approvals for Covaxin increasing, exports to additional countries will also commence from December.

“Bharat Biotech thanks the Government of India for approving exports. Covaxin will now become an integral part of the global fight against this pandemic,” said the company.

Published on November 29, 2021 09:00